Willdan Group, Inc. (NASDAQ:WLDN) announced the planned date for the release of its second quarter 2015 financial results and the related conference call to discuss such results. On Thursday, August 13, 2015, after market close, Willdan plans to announce its second quarter 2015 financial results. Willdan Group, Inc. (NASDAQ:WLDN) belongs to Services sector. Its net profit margin is 8.10% and weekly performance is 1.06%. On last trading day company shares ended up $10.45. Willdan Group, Inc. (NASDAQ:WLDN) distance from 50-day simple moving average (SMA50) is -11.82%.
Marin Software (NYSE: MRIN) reported Q2 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $26.8 million versus the consensus estimate of $26.99 million. Marin Software Incorporated (NYSE:MRIN) shares moved down -28.14% in last trading session and ended the day at $4.01. MRIN Gross Margin is 64.20% and its return on assets is -32.30%. Marin Software Incorporated (NYSE:MRIN) quarterly performance is -33.61%.
ProPhase Labs, Inc. (NASDAQ: PRPH) announced that as of July 30, 2015, it entered into an Investment Agreement (the “Investment Agreement”) with Dutchess Opportunity Fund, II, LP, a Delaware limited partnership (“Dutchess”). Pursuant to the Investment Agreement, Dutchess committed to purchase, subject to certain restrictions and conditions, up to 3,200,000 shares of the Company’s common stock, over a period of 36 months from the first trading day following the effectiveness of the registration statement registering the resale of shares purchased by Dutchess pursuant to the Investment Agreement. On 06 August, ProPhase Labs, Inc. (NASDAQ:PRPH) shares moved up 0.71% and was closed at $1.41. PRPH EPS growth in last 5 year was -9.40%. ProPhase Labs, Inc. (NASDAQ:PRPH) year to date (YTD) performance is -3.42%.
Cleantech Solutions International, Inc. (NASDAQ:CLNT) ended the last trading day at $2.51. Company weekly volatility is calculated as 6.70% and price to cash ratio as 0.76. Cleantech Solutions International, Inc. (NASDAQ:CLNT) showed a weekly performance of -5.99%.
Investment analysts at Susquehanna assumed coverage on shares of Impax Laboratories (NASDAQ:IPXL) in a note issued to investors on Monday, TheFlyOnTheWall.com reports. The firm set a “positive” rating and a $60.00 price target on the specialty pharmaceutical company’s stock. Susquehanna’s target price suggests a potential upside of 21.88% from the stock’s previous close. Impax Laboratories Inc. (NASDAQ:IPXL) shares moved down -3.32% in last trading session and ended the day at $46.30. IPXL Gross Margin is 50.60% and its return on assets is 3.60%. Impax Laboratories Inc. (NASDAQ:IPXL) quarterly performance is 4.16%.